Rupali Deshraj Nirmal, 16, reacts as she receives a dose of Bharat Biotech’s COVID-19 vaccine, Covaxin, in Mumbai, India, January 3, 2022. REUTERS/Niharika Kulkarni
Reuters /
Monday, January 03, 2022
Rupali Deshraj Nirmal, 16, reacts as she receives a dose of Bharat Biotech’s COVID-19 vaccine, Covaxin, in Mumbai, India, January 3, 2022. REUTERS/Niharika Kulkarni
Close